Skip to main content
. 2019 Dec 16;12:28–34. doi: 10.1016/j.ijpddr.2019.12.002

Table 2.

Egg reappearance periods following moxidectin single active and two combination treatments. The ERPs are defined when the mean heard efficacy was <85%. The actual percent efficacies are included in parentheses.

Treatment Time of ERP in weeks
MOX, single active 16 (67.2%)
1st Combination Treatment (MOX/OBZ) 12 (80.4%)
2nd Combination Treatment (MOX/OBZ) 18 (82.5%)

Abbreviations: MOX, moxidectin; OBZ, oxibendazole; ERP, egg reappearance period.